- No file added yet -
Receptor-selective TRAIL Mutants Target Lymphoid Tumor cells for Apoptosis via TRAIL-R1: Implications for Therapy.
journal contribution
posted on 2009-02-04, 10:12 authored by Marion MacFarlane, Susan Louise Kohlhaas, Michael J. Sutcliffe, Martin J. S. Dyer, Gerald M. CohenReceptor-selective TRAIL Mutants Target Lymphoid Tumor cells for Apoptosis via TRAIL-R1: Implications for Therapy.
History
Citation
Toxicology, 2008, 253 (1-3), pp. 6-7.Published in
ToxicologyPublisher
Elsevier.issn
0378-4274Copyright date
2008Available date
2009-02-04Publisher DOI
Publisher version
http://www.sciencedirect.com/science/article/pii/S0300483X0800334X?np=yLanguage
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC